Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Price-To-Tangible-Book-Ratio" stands at 1.75 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Price To Tangible Book Ratio" stands at 1.75. This represents a decrease of -9.41 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -13.61 percent compared to the value the year prior.
The 1 year change in percent is -13.61.
The 3 year change in percent is -15.79.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Tangible Book Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Tangible Book Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Tangible Book Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Tangible Book Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price To Tangible Book Ratio | 280,205,508,085.11 |